Headache News and Research

Latest Headache News and Research

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Allergan is pleased to announce that BOTOX has received a positive opinion from the Irish Medicines Board for the management of urinary incontinence in adults with neurogenic detrusor overactivity (NDO) resulting from neurogenic bladder due to stable sub-cervical spinal cord injury, or multiple sclerosis.

8 Aug 2011

Michigan Neurosport Concussion Program offers free online courses for high school coaches

Spencer Helgren was bawling his eyes out, but it was the fourth quarter and he wasn't going to sit down on the sidelines. He kept playing through the tears. It was the first of several head injuries on the football field for the junior from Westwood High school in Michigan's Upper Peninsula. At the time, he just thought he'd had his bell rung and he'd be fine - despite the unusual crying spell.

6 Aug 2011

Tips to prevent heat stroke among school football players

Practices for football, cross country and other high school sports are starting up this month, and many athletes will do two-a-day workouts in the August heat. Last year, four high school football players died of heat stroke, according to the Annual Survey of Football Injury Research.

6 Aug 2011

First anti-venom for scorpion bites approved by FDA

The U.S. Food and Drug Administration (FDA) has approved a Mexican-made drug that is the first specific treatment for stings by the most common type of scorpion in the United States. The new preparation called Anascorp is found to have few allergic reactions and was approved after a series of clinical trials by the University of Arizona.

5 Aug 2011

Tips to minimize risk of bug bites and related illnesses

While the image of a bug crawling on your arm or a creepy crawler snuggling up in your bed is enough to make you flinch, most bug bites are harmless and disappear on their own in a matter of days. Other insects, however, can spread disease and cause severe reactions that require medical attention.

4 Aug 2011

Researchers discover new tick-borne bacterium that causes ehrlichiosis in Wis., Minn.

A new tick-borne bacterium infecting humans with ehrlichiosis has been discovered in Wisconsin and Minnesota. It was identified as a new strain of bacteria through DNA testing conducted at Mayo Clinic.

4 Aug 2011

Mich. physicians group seeks standing in Kan. abortion case; Mass. anti-abortion group pushes to overturn health law

The American Association of Pro-Life Obstetricians and Gynecologists is seeking to appeal a federal court ruling that temporarily blocked the Kansas law, the Kansas City Star reports. Meanwhile, the effort by abortion opponents in Massachusetts could be a complication for presidential candidate Mitt Romney.

4 Aug 2011

'Concussions in the Classroom' program for high school teachers

According to a recent study by the American Academy of Pediatrics, concussions among middle and high school students are skyrocketing sending more than 100,000 adolescents and children a year to the emergency room.

4 Aug 2011

Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

The U.S. Food and Drug Administration today approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States.

4 Aug 2011

Acceleron, Celgene enter development collaboration for ACE-536 protein therapeutic to treat anemia

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, and Celgene Corporation today announced that the companies have entered into a joint development and commercialization agreement for ACE-536 for the treatment of anemia.

3 Aug 2011

FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing

MAP Pharmaceuticals, Inc. today announced that its New Drug Application (NDA) for LEVADEX® orally inhaled migraine drug for the potential acute treatment of migraine in adults has been accepted for filing by the U.S. Food and Drug Administration (FDA), with a goal date of March 26, 2012 under the Prescription Drug User Fee Act (PDUFA).

2 Aug 2011

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.

30 Jul 2011

Viewpoints: Sanders on angry Americans; Sebelius on Md. exchanges; Samuelson: 'it's the elderly, stupid'

If the Republicans have their way, the entire burden of deficit reduction will be placed on the elderly, the sick, children and working families. In the midst of a horrendous recession that is already causing severe pain for average Americans, this approach is morally grotesque. ... The Reid plan is bad. The constantly shifting plan by House Speaker John Boehner is much worse. ... Those cuts would mean drastic reductions in Social Security, Medicare and Medicaid.

30 Jul 2011

Cadence confirms FDA dosing recommendations for OFIRMEV

Cadence Pharmaceuticals, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) approved dosing recommendations for OFIRMEV (acetaminophen) injection remains 4,000 mg per day for adults and adolescents weighing at least 50 kg.

29 Jul 2011

Stroke in pregnancy on the rise

According to latest reports the number of strokes among pregnant women and new mothers has risen to a new peak probably because more of them are obese and suffering from high blood pressure and heart disease.

29 Jul 2011

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), an investigational medication for type 2 diabetes.

28 Jul 2011

POZEN reports revenue of $4.6 million for second quarter 2011

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced results for the second quarter ended June 30, 2011.

28 Jul 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced results of operations for the second quarter of 2011.

27 Jul 2011

Mayo Clinic releases recommendations from the ice hockey concussion summit

Mayo Clinic has released recommendations from the Ice Hockey Summit on Concussion: A Call to Action. The summit attracted top scientists, trainers, coaches, officials and equipment manufacturers from across the United States, Canada and Europe to discuss concussion-related issues, including the science of concussions, impact on children, and prevention.

27 Jul 2011

Patients with MTBI exhibit abnormal functional connectivity in the thalamus

A new study has found that patients with mild traumatic brain injury (MTBI) exhibit abnormal functional connectivity in the thalamus, a centrally located relay station for transmitting information throughout the brain.

26 Jul 2011

Headache News and Research

Latest Headache News and Research

Allergan receives positive opinion from Irish Medicines Board for BOTOX

Michigan Neurosport Concussion Program offers free online courses for high school coaches

Tips to prevent heat stroke among school football players

First anti-venom for scorpion bites approved by FDA

Tips to minimize risk of bug bites and related illnesses

Researchers discover new tick-borne bacterium that causes ehrlichiosis in Wis., Minn.

Mich. physicians group seeks standing in Kan. abortion case; Mass. anti-abortion group pushes to overturn health law

'Concussions in the Classroom' program for high school teachers

Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting

Acceleron, Celgene enter development collaboration for ACE-536 protein therapeutic to treat anemia

FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

Viewpoints: Sanders on angry Americans; Sebelius on Md. exchanges; Samuelson: 'it's the elderly, stupid'

Cadence confirms FDA dosing recommendations for OFIRMEV

Stroke in pregnancy on the rise

Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON

POZEN reports revenue of $4.6 million for second quarter 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Mayo Clinic releases recommendations from the ice hockey concussion summit

Patients with MTBI exhibit abnormal functional connectivity in the thalamus

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in